benzyl (2S,3R,3aS,3'R,4a'R,6S,6a'R,6b'S,7aR,12a'S,12b'S)-3'-azido-3,6,11',12b'-tetramethyl-2',3,3a,3',4',4a',5,5',6,6',6a',6b',7,7a,7',8',10',12',12a',12b'-icosahydro-1'H,4H-spiro[furo[3,2-b]pyridine-2,9'-naphtho[2,1-a]azulene]-4-carboxylate

更新时间:2023-10-09 19:40:54

benzyl (2S,3R,3aS,3'R,4a'R,6S,6a'R,6b'S,7aR,12a'S,12b'S)-3'-azido-3,6,11',12b'-tetramethyl-2',3,3a,3',4',4a',5,5',6,6',6a',6b',7,7a,7',8',10',12',12a',12b'-icosahydro-1'H,4H-spiro[furo[3,2-b]pyridine-2,9'-naphtho[2,1-a]azulene]-4-carboxylate结构式
benzyl (2S,3R,3aS,3'R,4a'R,6S,6a'R,6b'S,7aR,12a'S,12b'S)-3'-azido-3,6,11',12b'-tetramethyl-2',3,3a,3',4',4a',5,5',6,6',6a',6b',7,7a,7',8',10',12',12a',12b'-icosahydro-1'H,4H-spiro[furo[3,2-b]pyridine-2,9'-naphtho[2,1-a]azulene]-4-carboxylate结构式
委托求购
常用名 benzyl (2S,3R,3aS,3'R,4a'R,6S,6a'R,6b'S,7aR,12a'S,12b'S)-3'-azido-3,6,11',12b'-tetramethyl-2',3,3a,3',4',4a',5,5',6,6',6a',6b',7,7a,7',8',10',12',12a',12b'-icosahydro-1'H,4H-spiro[furo[3,2-b]pyridine-2,9'-naphtho[2,1-a]azulene]-4-carboxylate 英文名 benzyl (2S,3R,3aS,3'R,4a'R,6S,6a'R,6b'S,7aR,12a'S,12b'S)-3'-azido-3,6,11',12b'-tetramethyl-2',3,3a,3',4',4a',5,5',6,6',6a',6b',7,7a,7',8',10',12',12a',12b'-icosahydro-1'H,4H-spiro[furo[3,2-b]pyridine-2,9'-naphtho[2,1-a]azulene]-4-carboxylate
CAS号 1037210-95-9 分子量 586.80700
密度 N/A 沸点 N/A
分子式 C36H50N4O3 熔点 N/A
MSDS N/A 闪点 N/A

 名称

英文名 benzyl (2S,3R,3aS,3'R,4a'R,6S,6a'R,6b'S,7aR,12a'S,12b'S)-3'-azido-3,6,11',12b'-tetramethyl-2',3,3a,3',4',4a',5,5',6,6',6a',6b',7,7a,7',8',10',12',12a',12b'-icosahydro-1'H,4H-spiro[furo[3,2-b]pyridine-2,9'-naphtho[2,1-a]azulene]-4-carboxylate

 物理化学性质

分子式 C36H50N4O3
分子量 586.80700
精确质量 586.38800
PSA 88.52000
LogP 8.22976

 合成线路

~%

benzyl (2S,3R,3aS,3'R,4a'R,6S,6a'R,6b'S,7aR,12a'S,12b'S)-3'-azido-3,6,11',12b'-tetramethyl-2',3,3a,3',4',4a',5,5',6,6',6a',6b',7,7a,7',8',10',12',12a',12b'-icosahydro-1'H,4H-spiro[furo[3,2-b]pyridine-2,9'-naphtho[2,1-a]azulene]-4-carboxylate结构式

benzyl (2S,3R,3...

1037210-95-9

文献:INFINITY PHARMACEUTICALS, INC.; AUSTAD, Brian; BAHADOOR, Adilah; BELANI, Jitendra, D.; JANARDANANNAIR, Somarajannair; JOHANNES, Charles, W.; KEANEY, Gregg, F.; LO, Ching, Kam; WALLERSTEIN, Sheldon, L. Patent:   WO2011/17551 A1, 2011 ; Location in patent: Page/Page column 15 ;

~%

benzyl (2S,3R,3aS,3'R,4a'R,6S,6a'R,6b'S,7aR,12a'S,12b'S)-3'-azido-3,6,11',12b'-tetramethyl-2',3,3a,3',4',4a',5,5',6,6',6a',6b',7,7a,7',8',10',12',12a',12b'-icosahydro-1'H,4H-spiro[furo[3,2-b]pyridine-2,9'-naphtho[2,1-a]azulene]-4-carboxylate结构式

benzyl (2S,3R,3...

1037210-95-9

文献:INFINITY PHARMACEUTICALS, INC.; AUSTAD, Brian; BAHADOOR, Adilah; BELANI, Jitendra, D.; JANARDANANNAIR, Somarajannair; JOHANNES, Charles, W.; KEANEY, Gregg, F.; LO, Ching, Kam; WALLERSTEIN, Sheldon, L. Patent:   WO2011/17551 A1, 2011 ;